Literature DB >> 7680947

Malignant ascites. A comparison of peritoneovenous shunting and nonoperative management.

I R Gough1, G A Balderson.   

Abstract

BACKGROUND: Effective palliation of malignant ascites remains a difficult management problem.
METHODS: Eighty-five patients with malignant ascites were studied. Forty-two patients had peritoneovenous shunts (PVS) inserted (16 LeVeen, 17 single-valve Denver, 9 double-valve Denver).
RESULTS: Shunt patency was not related to the type of shunt, type of cancer, or any characteristic of the ascitic fluid. Ascites was controlled in 64% of patients with shunts and serum albumin levels were preserved. Survival and quality of life were not significantly different in comparison with those of patients treated by abdominal paracentesis.
CONCLUSIONS: PVS allowed many patients to be treated successfully outside the hospital and are indicated in carefully selected cases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7680947     DOI: 10.1002/1097-0142(19930401)71:7<2377::aid-cncr2820710732>3.0.co;2-h

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.

Authors:  Suma L Sangisetty; Thomas J Miner
Journal:  World J Gastrointest Surg       Date:  2012-04-27

2.  A survey of treatment approaches of malignant ascites in Germany and Austria.

Authors:  C F Jehn; S Küpferling; G Oskay-Özcelik; D Lüftner
Journal:  Support Care Cancer       Date:  2014-12-21       Impact factor: 3.603

3.  Palliative treatment of malignant ascites: profile of catumaxomab.

Authors:  Lila Ammouri; Eric E Prommer
Journal:  Biologics       Date:  2010-05-25

4.  Symptom management in hepatocellular carcinoma.

Authors:  Virginia Chih-Yi Sun; Linda Sarna
Journal:  Clin J Oncol Nurs       Date:  2008-10       Impact factor: 1.027

Review 5.  Symptomatic Fluid Drainage: Peritoneovenous Shunt Placement.

Authors:  Hooman Yarmohammadi; George I Getrajdman
Journal:  Semin Intervent Radiol       Date:  2017-12-14       Impact factor: 1.513

6.  Feasibility of externalized peritoneovenous shunt (EPVS) for malignant ascites.

Authors:  Hiroyuki Tokue; Yoshito Takeuchi; Yasuaki Arai; Keitaro Sofue; Noriaki Sakamoto; Yoshito Tsushima; Keigo Endo
Journal:  World J Surg Oncol       Date:  2011-07-21       Impact factor: 2.754

Review 7.  Drainage of malignant ascites: patient selection and perspectives.

Authors:  Maciej Stukan
Journal:  Cancer Manag Res       Date:  2017-04-12       Impact factor: 3.989

8.  A survey of practice in management of malignancy-related ascites in Japan.

Authors:  Yoshiaki Kanai; Hiroto Ishiki; Isseki Maeda; Satoru Iwase
Journal:  PLoS One       Date:  2019-08-09       Impact factor: 3.240

9.  Development and validation of the self-completed ascites impact measure to understand patient motivation for requesting a paracentesis.

Authors:  Bruce Crawford; Elizabeth Piault; Walter Gotlieb; Florence Joulain
Journal:  Patient Relat Outcome Meas       Date:  2012-06-21

10.  Management of drainage for malignant ascites in gynaecological cancer.

Authors:  Chumnan Kietpeerakool; Siwanon Rattanakanokchai; Nampet Jampathong; Jatupol Srisomboon; Pisake Lumbiganon
Journal:  Cochrane Database Syst Rev       Date:  2019-12-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.